TXG 10x Genomics, Inc.
Company Analysis
Latest News
🔴 10x Genomics is trading 5% down in pre-market amid broader technology-market weakness
10x Genomics is trading at $79.48, down 4.95%, amid broader technology-market weakness; no company-specific announcement explaining the decline was...
🟢 10x Genomics is trading 10% up today with biotech-sector strength as context
10x Genomics is trading at $85.87, up 10.06%, with biotech-sector strength as context; no company-specific catalyst is confirmed. - Search results surfaced no...
🟢 10x Genomics is trading at 5.9% up today with biotech shares higher
10x Genomics is trading 5.9% higher at $82.62; biotech-sector strength is the best available context, not a confirmed direct cause. - No clear company-specific...
🟢 10x Genomics is trading 5% up with no clear company-specific catalyst identified
10x Genomics is trading at $76.61, up 5.00%, with no clear company-specific announcement explaining the October 27 move. - The company’s investor news page...
🔴 10x Genomics is trading 10.21% down today amid tech selloff on AI-spending and oil-price concerns
10x Genomics is trading 10.21% lower at $67.87 as investors retreat from technology stocks amid concerns about AI spending and rising oil prices. - The Nasdaq...
🔴 10x Genomics is trading 6.2% down today amid oil gains and technology-spending concerns
10x Genomics is trading 6.23% down at $72.22 now on October 22, 2026, amid a broad risk-off session. - Reuters reported renewed pressure on growth stocks as...
🟢 10x Genomics is trading 4.3% up today amid positive biotech-sector sentiment
10x Genomics is trading 4.32% up at $74.55 on October 21, 2026, with the move appearing consistent with positive biotech-sector sentiment rather than a direct...
🟢 10x Genomics rises 4.1% — Biotech Sector Surges on M&A Activity and Positive Clinical Trial Data
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector is experiencing a significant...
🔴 10x Genomics falls 5.2% — Biotech Sector Declines Amid Broad Market Rotation
With Biotech (XBI) down 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as represented by the XBI...
🔴 10x Genomics is trading 5% down as hotter U.S. inflation fuels rate concerns
10x Genomics is trading at $70.33, with a -4.80% change, amid broader technology weakness. - No clear company-specific announcement explains the October 15...
🔴 10x Genomics is trading 5% down in pre-market amid rate concerns weighing on technology shares
10x Genomics is trading 4.91% lower at $69.51 in pre-market on October 15, with no clear company-specific announcement explaining the decline; broader...
🔴 10x Genomics is trading 4.4% down today amid valuation concerns
10x Genomics is trading 4.4% down at $71.88 on October 13, as coverage cites valuation concerns and profit-taking after a substantial rally. - The stock fell...
🔴 10x Genomics is trading 10% down on October 12, 2026 — with no confirmed company-specific catalyst
10x Genomics is trading at $72.43, down 10.19%, with no confirmed company-specific catalyst identified for the October 12 decline. - Latest surfaced company...
🔴 10x Genomics is trading 4.1% down with no clear catalyst identified
10x Genomics is trading 4.1% lower at $77.35 on October 12, 2026; no confirmed company-specific catalyst has been identified. - Recent coverage has discussed...
🟢 10x Genomics is trading 6% up
10x Genomics is trading at $82.04, up 6.16%, with no confirmed company-specific announcement or direct catalyst for the October 9 move in available...
🔴 10x Genomics is trading 6.7% down amid higher yields and oil prices
10x Genomics is trading at $71.01, down 6.69%, amid broader market pressure consistent with higher oil prices and Treasury yields. - No clear company-specific...
🔴 10x Genomics is trading 5% down in pre-market amid rising yields and oil prices
10x Genomics is trading at $72.53, down 4.69% in pre-market amid broader market pressure; no clear company-specific catalyst was identified. - Shares fell...
🔴 10x Genomics is trading 6.8% down today as major indexes fall amid rising yields
10x Genomics is trading 6.8% down at $73.86 amid broader market pressure, with no fresh company-specific catalyst identified. - The S&P 500, Nasdaq and Dow are...
🔴 10x Genomics is trading 10.2% down today amid biotech weakness, with no new company-specific catalyst identified
10x Genomics is trading at $87.76, down 10.21%, with biotech-sector weakness as relevant context; no fresh company-specific announcement explaining the October...
🔴 10x Genomics is trading 6.5% down today amid biotech-sector weakness
10x Genomics is trading at $91.39, down 6.50%, with no fresh company-specific announcement explaining the decline. - The latest company news found was...